GBA1 and Parkinson disease: This reduces the total accumulation of substrates resulting from mutations in GBA1. Some mutations, like the intriguing case of E326K do not cause substrate accumulation or GD despite a high prevalence in PD patients (Nichols et al., 2009; Pankratz et al., 2012).